Published in Biotech Business Week, July 25th, 2005
Trading in ChemGenex ADRs was slated to begin Tuesday June 28, 2005.
Each ADR will represent 15 ordinary shares. The ordinary shares will continue to trade on the Australian Stock Exchange under the ASX code "CXS." The company has selected the Bank of New York to administer its ADR program.
"This is an important step in the growth of ChemGenex as an international pharmaceutical company," said Greg Collier, PhD, CEO and managing director of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.